Advertisement

 

 

DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.

DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice.
Author Information (click to view)

Zhou JJ, Wang YM, Lee VWS, Zhang GY, Medbury H, Williams H, Wang Y, Tan TK, Harris DCH, Alexander SI, Durkan AM,


Zhou JJ, Wang YM, Lee VWS, Zhang GY, Medbury H, Williams H, Wang Y, Tan TK, Harris DCH, Alexander SI, Durkan AM, (click to view)

Zhou JJ, Wang YM, Lee VWS, Zhang GY, Medbury H, Williams H, Wang Y, Tan TK, Harris DCH, Alexander SI, Durkan AM,

Advertisement

PloS one 2018 04 1113(4) e0195657 doi 10.1371/journal.pone.0195657
Abstract

Studies disrupting the chemokine pathway CX3CL1 (fractalkine)/ CX3CR1 have shown decreased atherosclerosis in animal models but the techniques used to interrupt the pathway have not been easily translatable into human trials. DNA vaccination potentially overcomes the translational difficulties. We evaluated the effect of a DNA vaccine, targeted to CX3CR1, on atherosclerosis in a murine model and examined possible mechanisms of action. DNA vaccination against CX3CR1, enhanced by dendritic cell targeting using DEC-205 single chain variable region fragment (scFv), was performed in 8 week old ApoE-/- mice, fed a normal chow diet. High levels of anti-CX3CR1 antibodies were induced in vaccinated mice. There were no apparent adverse reactions to the vaccine. Arterial vessels of 34 week old mice were examined histologically for atherosclerotic plaque size, macrophage infiltration, smooth muscle cell infiltration and lipid deposition. Vaccinated mice had significantly reduced atherosclerotic plaque in the brachiocephalic artery. There was less macrophage infiltration but no significant change to the macrophage phenotype in the plaques. There was less lipid deposition in the lesions, but there was no effect on smooth muscle cell migration. Targeted DNA vaccination to CX3CR1 was well tolerated, induced a strong immune response and resulted in attenuated atherosclerotic lesions with reduced macrophage infiltration. DNA vaccination against chemokine pathways potentially offers a potential therapeutic option for the treatment of atherosclerosis.

Submit a Comment

Your email address will not be published. Required fields are marked *

20 + 17 =

[ HIDE/SHOW ]